Clinical Trials Browser

Active not recruiting × Triple Negative Breast Neoplasms × poly ICLC × Clear all

NCT02826434 2025-10-01

Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms